T0	Participants 55 124	NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype.
T1	Participants 201 243	patients with acute myeloid leukemia (AML)
T2	Participants 305 343	648 normal karyotype (NK) AML patients
T3	Participants 530 575	329 patients with a mutated NPM1 gene (NPM1+)
T4	Participants 588 634	319 patients without a NPM1 mutation (wtNPM1).
T5	Participants 820 834	NPM1+ subgroup
T6	Participants 1060 1077	NPM1-mutated AML.